S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

WINT Windtree Therapeutics Inc

1.78

-0.12 (-6.32%)

11 Mar 2025 - Closed

Delayed by 15 minutes

Form ARS - Annual Report to Security Holders

Windtree Therapeutics (NASDAQ:WINT)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Windtree Therapeutics Charts.

Windtree Therapeutics (NASDAQ:WINT)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Windtree Therapeutics Charts.

Windtree Therapeutics Inc News

Windtree Announces Istaroxime Notice of Allowance from the U.S. Patent and Trademark Office for Acute Heart Failure
Wednesday 5 March 2025 (7 days ago) • GlobeNewswire Inc.

Windtree Files Istaroxime Cardiogenic Shock and Prevention of Arrythmias Patent for India
Friday 28 February 2025 (2 weeks ago) • GlobeNewswire Inc.

Windtree Therapeutics, Inc. Announces Reverse Stock Split
Wednesday 19 February 2025 (3 weeks ago) • GlobeNewswire Inc.

Windtree Announces Special Late-Breaking Clinical Science Abstract Presentation on Istaroxime at the Technology and Heart Failure Therapeutics Conference
Thursday 13 February 2025 (4 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Tuesday 4 February 2025 (1 month ago) • Edgar (US Regulatory)

Windtree Strengthens Global Intellectual Property Portfolio with New Japanese Patent For the Company’s Oncology Pipeline
Thursday 16 January 2025 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Tuesday 14 January 2025 (2 months ago) • Edgar (US Regulatory)

Windtree Announces the Addition of Leanne Kelly to Its Board of Directors
Tuesday 14 January 2025 (2 months ago) • GlobeNewswire Inc.

Form DEF 14A - Other definitive proxy statements
Thursday 9 January 2025 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 9 January 2025 (2 months ago) • Edgar (US Regulatory)

Windtree Therapeutics Announces New Corporate Strategy Seeking to Identify and Acquire FDA-Approved Revenue Assets While Advancing Its Cardiovascular and Oncology Pipeline
Thursday 9 January 2025 (2 months ago) • GlobeNewswire Inc.

Windtree Announces Istaroxime Presentation By Cardiogenic Shock Thought Leader At Cardiovascular Clinical Trials Conference
Tuesday 17 December 2024 (3 months ago) • GlobeNewswire Inc.

More Windtree Therapeutics Inc News Articles

Leonteq Securities

Societe Generale Effekten

Vontobel Financial Produ...

Graniteshares 3x Long Un...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions